<DOC>
	<DOCNO>NCT01607307</DOCNO>
	<brief_summary>A multicenter randomized-controlled trial daikenchuto ( TJ-100 ) , traditional Japanese herbal medicine ( Kampo ) , investigate effect intestinal dysmotility prevention postoperative paralytic ileus .</brief_summary>
	<brief_title>Daikenchuto Intestinal Dysmotility Prevention Postoperative Paralytic Ielus After Pancreaticoduodenectomy</brief_title>
	<detailed_description>Daikenchuto ( TJ-100 ) , traditional Japanese herbal medicine , use prevention treatment postoperative ileus . TJ-100 extract powder ( Tsumura &amp; Co. , Tokyo , Japan ) manufacture aqueous extract contain 2.2 % Japanese pepper , 5.6 % process ginger , 3.3 % ginseng , 88.9 % maltose syrup powder . A recent randomize , parallel-group , double-blind , placebo-controlled , dose-response trial demonstrate TJ-100 accelerates colonic transit time , particularly ascend colon . Given potential action intestinal tract , seem reasonable postulate TJ-100 may play role improve prevent bowel dysmotility . This study design investigate effect TJ-100 intestinal dysmotility prevention postoperative paralytic ileus patient undergo pancreaticoduodenectomy . The primary endpoint incidence postoperative paralytic ileus . Secondary endpoint QOL assessment Gastrointestinal Symptom Rating Scale ( GSRS ) Score ( Japanese Version ) visual analogue scale , change ratio abdominal circumference , incidence postoperative complication , length hospital day , incidence surgical site infection . Two hundred patient require study ( 100 patient per group ) .</detailed_description>
	<mesh_term>Ileus</mesh_term>
	<mesh_term>Intestinal Pseudo-Obstruction</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Patients periampullary tumor ( extrahepatic bile duct tumor , tumor ampulla Vater duodenal tumor ) pancreatic tumor ( pancreatic cancer , intraductal papillary mucinous neoplasm pancreas , pancreatic endocrine tumor pancreatic neuroendocrine tumor ) head pancreas schedule undergo PD . Age least 20 year old time registration . All patient provide write informed consent initiation studyrelated procedure . Clinically problematic cardiac disease . Liver cirrhosis active hepatitis . Severe pulmonary disease ( interstitial pneumonia , pulmonary fibrosis , pulmonary emphysema etc. ) . Chronic renal failure require hemodialysis . Other malignant disease influence adverse effect . Patients tumor require resection colon . Patients expect severe intraabdominal adhesion due past surgical history past peritonitis history . Patients use gastrointestinal prokinetic medication , antipsychotic medication antidepressant . Patients use Japanese herbal ( Kampo ) medicine within 4 week registration . Pregnant lactating woman . Any medical condition make patient unsuitable inclusion study accord opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>daikenchuto</keyword>
	<keyword>postoperative ileus</keyword>
	<keyword>pancreaticoduodenectomy</keyword>
</DOC>